Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2024 08:05 ET | Source: Shareholder Capital LLC

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
March 23, 2021 07:15 ET | Source: Shareholders Foundation, Inc.

NASDAQ: VNDA Investor Notice: Update in Lawsuit against Vanda Pharmaceuticals Inc. announced by Shareholders Foundation

SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). ...
February 24, 2021 10:05 ET | Source: PMI

Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMI

Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...
February 11, 2019 10:49 ET | Source: Block & Leviton LLP

Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...